speb/financial-data huggingface dataset:
Financial ratios for ALRM — quarterly report dated 2025-12-31
Total revenue: 261657000
Gross profit: 172620000
Operating income: 34948000
Net income: 34734000
Capital expenditures: 860000
Operating cash flow: 35929000
Depreciation & amortization: 11650000
Net tangible assets: 523824000
Owner earnings: 45524000
Return on net tangible assets (%): 8.690705275054217
Capex to operating income (%): 2.4607989012246767
Buffett classification: The Great
Stock price: 51.02
P/E ratio: 19.03449352557817
Shares outstanding: 49460583
Book value: 891010000
P/B ratio: 2.832155581486179
Market cap (USD): 2523478944.6600003
Debt to equity: 1.1959921886398581
Current ratio: 1.9189175739662816
Quick ratio: 1.7765207950055795
Effective tax rate (%): 21.589409896916436
Interest coverage ratio: 8.065543503346412
COGS to revenue (%): 34.028136071268875
R&D to revenue (%): 25.28309963043221
SG&A to revenue (%): 24.0960494081947
Free cash flow (dilution-adjusted): 28217000
Buyback yield (%): 0.7585559626129192
Retained earnings: 522876000
Inventory turnover: 0.9428988975844285
Receivables turnover: 1.8445774469165046
Capitalized R&D asset: 133594890
ROCI (R&D-adjusted, %): 2.1042128838440743
Rosenberg metric: 0.05675525608895959
FCF margin (%): 10.783965267506698
Revenue growth (%): 2.050312012480499
Rule of 40 score: 12.834277279987198
Financial ratios for ALX.AX — annual report dated 2021-12-31
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 3.3695652173913047
Shares outstanding: 1451029344
Market cap (USD): 4889338006.956522
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for ALX.AX — annual report dated 2022-12-31
Total revenue: 78870270.27027027
Gross profit: 43816216.216216214
Operating income: -16797972.972972974
Net income: 180377702.7027027
Capital expenditures: 208783.7837837838
Depreciation & amortization: 44760135.13513514
Net tangible assets: 2911312837.8378377
Owner earnings: 224929054.05405405
Return on net tangible assets (%): 7.726035180097769
Buffett classification: The Gruesome
Stock price: 3.4054054054054053
P/E ratio: 27.394423464876628
Shares outstanding: 1451029344
Book value: 4385454054.054054
P/B ratio: 1.1267574829319036
Market cap (USD): 4941343171.459459
Debt to equity: 0.2673662254455454
Current ratio: 4.310886480983201
Quick ratio: 4.310886480983201
Effective tax rate (%): 1.3067051047902967
Interest coverage ratio: -0.2733239517139779
COGS to revenue (%): 44.44520594887259
Free cash flow (dilution-adjusted): 49614189.18918919
Buyback yield (%): 0.10728563403511926
Retained earnings: -396306756.7567568
Receivables turnover: 15.493496150783116
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): -0.3033762737080974
FCF margin (%): 62.90607223631005
Rule of 40 score: 62.90607223631005
Financial ratios for ALX.AX — annual report dated 2023-12-31
Total revenue: 91232876.71232878
Gross profit: 84178082.19178082
Operating income: -4041095.890410959
Net income: 221575342.46575344
Capital expenditures: 547945.205479452
Depreciation & amortization: 47397260.2739726
Net tangible assets: 857945205.4794521
Owner earnings: 268424657.53424662
Return on net tangible assets (%): 31.286923199744532
Buffett classification: The Gruesome
Stock price: 3.226027397260274
P/E ratio: 21.12626958343122
Shares outstanding: 1451029344
Book value: 4270958904.1095896
P/B ratio: 1.0960209458977483
Market cap (USD): 4681060417.972603
Debt to equity: 0.2759157097953685
Current ratio: 2.904882154882155
Quick ratio: 2.904882154882155
Effective tax rate (%): 1.4230769230769231
Interest coverage ratio: -0.06113989637305699
COGS to revenue (%): 7.732732732732732
SG&A to revenue (%): 24.92492492492492
Free cash flow (dilution-adjusted): 57465753.42465754
Buyback yield (%): 0.0029263946443398533
Retained earnings: -501027397.260274
Receivables turnover: 3.6294277929155316
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): -0.07443949583012655
FCF margin (%): 62.98798798798798
Revenue growth (%): 15.67460894922091
Rule of 40 score: 78.66259693720889
Financial ratios for ALX.AX — quarterly report dated 2024-12-31
Capital expenditures: 0
Net tangible assets: 689875776.3975155
Buffett classification: The Gruesome
Stock price: 2.6024844720496896
Shares outstanding: 1451029344
Book value: 3920621118.0124226
P/B ratio: 0.9631844604670322
Market cap (USD): 3776281336.2484474
Debt to equity: 0.2927980735718133
Current ratio: 2.728965003723008
Quick ratio: 2.728965003723008
Buyback yield (%): 0
Retained earnings: -561180124.2236024
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for ALX.AX — annual report dated 2024-12-31
Total revenue: 90062111.80124223
Gross profit: 86149068.32298136
Operating income: -5031055.900621118
Net income: 208633540.3726708
Capital expenditures: 683229.8136645962
Depreciation & amortization: 43788819.875776395
Net tangible assets: 689875776.3975155
Owner earnings: 251739130.4347826
Return on net tangible assets (%): 36.49050148554965
Buffett classification: The Gruesome
Stock price: 2.6024844720496896
P/E ratio: 18.10006832795475
Shares outstanding: 1451029344
Book value: 3920621118.0124226
P/B ratio: 0.9631844604670322
Market cap (USD): 3776281336.2484474
Debt to equity: 0.2927980735718133
Current ratio: 2.728965003723008
Quick ratio: 2.728965003723008
Effective tax rate (%): 1.113505747126437
Interest coverage ratio: -0.08535300316122235
COGS to revenue (%): 4.344827586206896
SG&A to revenue (%): 24.275862068965516
Free cash flow (dilution-adjusted): 57204968.944099374
Buyback yield (%): 0
Retained earnings: -561180124.2236024
Receivables turnover: 12.083333333333332
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): -0.09965919017680279
FCF margin (%): 63.51724137931034
Revenue growth (%): -1.2832708484882542
Rule of 40 score: 62.233970530822084
Financial ratios for AN1.AX — annual report dated 2021-06-30
Capital expenditures: 16893.233082706767
Buffett classification: The Gruesome
Stock price: 0.045112781954887216
Shares outstanding: 985450795
Market cap (USD): 44456426.84210526
Buyback yield (%): 0.6409756866653094
Capitalized R&D asset: 89318.04511278195
Rule of 40 score: 0
Financial ratios for AN1.AX — annual report dated 2022-06-30
Total revenue: 6368878.620689656
Gross profit: 3493271.034482759
Operating income: -3146190.3448275863
Net income: -2516404.827586207
Capital expenditures: 24791.034482758623
Depreciation & amortization: 341160
Net tangible assets: 3328877.931034483
Owner earnings: -2200035.8620689656
Return on net tangible assets (%): -66.08941233796703
Buffett classification: The Gruesome
Stock price: 0.013793103448275864
Shares outstanding: 985450795
Book value: 5720722.758620691
P/B ratio: 2.3759978121886696
Market cap (USD): 13592424.75862069
Debt to equity: 0.2118261401260125
Current ratio: 2.3974206284665724
Quick ratio: 1.181544709024575
Interest coverage ratio: -65.30168909247065
COGS to revenue (%): 45.150924636329634
R&D to revenue (%): 1.1948944836713526
SG&A to revenue (%): 89.10334889247
Free cash flow (dilution-adjusted): -1766581.3793103448
Buyback yield (%): 0
Retained earnings: -37173371.03448276
Inventory turnover: 0.9374003923941099
Receivables turnover: 10.023927501104438
Capitalized R&D asset: 135944.46953590875
ROCI (R&D-adjusted, %): -47.857134019051024
FCF margin (%): -27.737714667249385
Rule of 40 score: -27.737714667249385
Financial ratios for AN1.AX — annual report dated 2023-06-30
Total revenue: 6035373.509933774
Gross profit: 2921525.1655629138
Operating income: -1546839.072847682
Net income: -1766324.5033112583
Capital expenditures: 30048.344370860927
Depreciation & amortization: 238294.70198675495
Net tangible assets: 3607276.821192053
Owner earnings: -1558078.145695364
Return on net tangible assets (%): -43.192641511235195
Buffett classification: The Gruesome
Stock price: 0.013245033112582781
Shares outstanding: 985450795
Book value: 5891015.894039735
P/B ratio: 2.215632862882238
Market cap (USD): 13052328.410596026
Debt to equity: 0.07355807485053568
Current ratio: 3.646428081562136
Quick ratio: 2.2481481589568637
Interest coverage ratio: -73.34904534606204
COGS to revenue (%): 51.59329972280422
R&D to revenue (%): 0.23254731980792273
SG&A to revenue (%): 64.47781259580658
Free cash flow (dilution-adjusted): -1194892.0529801324
Buyback yield (%): 1.377166680351605
Retained earnings: -37462607.94701987
Inventory turnover: 1.9626738451854309
Receivables turnover: 8.72271487790381
Capitalized R&D asset: 94497.97836289743
ROCI (R&D-adjusted, %): -25.204154651479488
Rosenberg metric: -7.5129501475688105
FCF margin (%): -19.798145897903904
Revenue growth (%): -5.23648087235438
Rule of 40 score: -25.034626770258285
Financial ratios for AN1.AX — annual report dated 2024-06-30
Total revenue: 7202112
Gross profit: 2907521.3333333335
Operating income: -4917856
Net income: -5162804
Capital expenditures: 65268.666666666664
Depreciation & amortization: 410843.3333333333
Net tangible assets: 504948.6666666667
Owner earnings: -4817229.333333334
Return on net tangible assets (%): -954.0037733208525
Buffett classification: The Gruesome
Stock price: 0.006666666666666667
Shares outstanding: 985450795
Book value: 2527323.333333333
P/B ratio: 2.599458438901763
Market cap (USD): 6569671.966666667
Debt to equity: 0.2038108829235674
Current ratio: 1.4562832632768172
Quick ratio: 0.6808335246034669
Interest coverage ratio: -111.23351126391024
COGS to revenue (%): 59.62960124289468
R&D to revenue (%): 0.08030977579909893
SG&A to revenue (%): 96.73444863580757
Free cash flow (dilution-adjusted): -1224149.3333333333
Buyback yield (%): 1.5147382371333924
Retained earnings: -42707832
Inventory turnover: 2.181606180943086
Receivables turnover: 16.58219594407913
Capitalized R&D asset: 40300.97172870518
ROCI (R&D-adjusted, %): -178.1872406013237
Rosenberg metric: -0.9977722203872127
FCF margin (%): -16.997088261517362
Revenue growth (%): 19.331669997654018
Rule of 40 score: 2.3345817361366556
Financial ratios for APXT — annual report dated 2025-12-31
Capital expenditures: 0
Net tangible assets: 334260127
Buffett classification: The Gruesome
Stock price: 9.89
Shares outstanding: 34470000
Book value: 334260127
P/B ratio: 1.0198892193922968
Market cap (USD): 340908300
Debt to equity: 0
Current ratio: 12.849005988023952
Quick ratio: 12.849005988023952
Buyback yield (%): 0
Retained earnings: -12731957
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for APXT — quarterly report dated 2025-12-31
Total revenue: 0
Operating income: -221923
Net income: 2069012
Capital expenditures: 0
Operating cash flow: -369663
Owner earnings: 2069012
Buffett classification: The Gruesome
Stock price: 9.89
P/E ratio: 41.192160799454044
Shares outstanding: 34470000
Market cap (USD): 340908300
Free cash flow (dilution-adjusted): -369663
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for ATEB.BR — annual report dated 2021-12-31
Capital expenditures: 0
Depreciation & amortization: 895454.5454545454
Buffett classification: The Gruesome
Stock price: 32.79545454545455
Shares outstanding: 60716353
Market cap (USD): 1991220394.9772727
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for ATEB.BR — annual report dated 2022-12-31
Total revenue: 43625531.91489362
Gross profit: 6993617.021276596
Operating income: 126595.74468085107
Net income: -896808.5106382979
Capital expenditures: 1240425.5319148938
Operating cash flow: -169346808.5106383
Depreciation & amortization: 924468.0851063831
Net tangible assets: 288457446.80851066
Owner earnings: -1212765.9574468085
Return on net tangible assets (%): -0.4204314954822054
Capex to operating income (%): 979.8319327731093
Buffett classification: The Gruesome
Stock price: 27.308510638297875
Shares outstanding: 60716353
Book value: 291082978.72340417
P/B ratio: 5.696221672221859
Market cap (USD): 1658073171.819149
Debt to equity: 3.262373089489728
Current ratio: 2.2776731795519978
Quick ratio: 0.1657976967909556
Effective tax rate (%): 488.12949640287763
Interest coverage ratio: 0.00718772650398647
COGS to revenue (%): 83.96898166211471
Free cash flow (dilution-adjusted): -170587234.0425532
Buyback yield (%): 0
Retained earnings: 188108510.6382979
Inventory turnover: 0.035779041507387206
Receivables turnover: 1.9230011723329425
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 0.014516426129079088
FCF margin (%): -391.02614124073347
Rule of 40 score: -391.02614124073347
Financial ratios for ATEB.BR — annual report dated 2023-12-31
Total revenue: 94902222.22222222
Gross profit: -1020000
Operating income: -15281111.11111111
Net income: -119032222.22222222
Capital expenditures: 916666.6666666666
Operating cash flow: -111181111.1111111
Depreciation & amortization: 63438888.88888889
Net tangible assets: 381004444.4444444
Owner earnings: -56510000
Return on net tangible assets (%): -14.831847980775962
Buffett classification: The Gruesome
Stock price: 8.266666666666667
Shares outstanding: 60716353
Book value: 382564444.4444444
P/B ratio: 1.311992943294957
Market cap (USD): 501921851.4666667
Debt to equity: 2.512311651196022
Current ratio: 2.0889758716027322
Quick ratio: 0.17658474974392913
Interest coverage ratio: -0.39854526486611797
COGS to revenue (%): 101.07479042757458
Free cash flow (dilution-adjusted): -112097777.77777778
Buyback yield (%): 0.0015495993559655392
Retained earnings: 57492222.222222224
Inventory turnover: 0.0869146750188518
Receivables turnover: 11.121354166666666
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): -1.7169702023959934
FCF margin (%): -118.11923383131176
Revenue growth (%): 117.53825811765725
Rule of 40 score: -0.5809757136545102
Financial ratios for ATEB.BR — annual report dated 2024-12-31
Total revenue: 346913541.6666667
Gross profit: 36015625
Operating income: 30191666.666666668
Net income: -40765625
Capital expenditures: 948958.3333333334
Operating cash flow: 169415625
Depreciation & amortization: 39332291.66666667
Net tangible assets: 301813541.6666667
Owner earnings: -2382291.666666662
Return on net tangible assets (%): -0.7893256391052683
Capex to operating income (%): 3.143113441898979
Buffett classification: The Great
Stock price: 3.5416666666666665
Shares outstanding: 60716353
Book value: 303503125.0000001
P/B ratio: 0.7085168679619578
Market cap (USD): 215037083.54166666
Debt to equity: 2.485329297131069
Current ratio: 1.9782080973241443
Quick ratio: 0.21281715020379602
Interest coverage ratio: 0.8434899016355276
COGS to revenue (%): 89.61827064260127
Free cash flow (dilution-adjusted): 168466666.6666667
Buyback yield (%): 0
Retained earnings: 12862500
Inventory turnover: 0.3628682031056233
Receivables turnover: 29.724830417707963
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 4.263167958580317
FCF margin (%): 48.56157123682954
Revenue growth (%): 265.54838605816514
Rule of 40 score: 314.1099572949947
Financial ratios for ATEB.BR — quarterly report dated 2024-12-31
Capital expenditures: 0
Net tangible assets: 301813541.6666667
Buffett classification: The Gruesome
Stock price: 3.5416666666666665
Shares outstanding: 60716353
Book value: 303503125.0000001
P/B ratio: 0.7085168679619578
Market cap (USD): 215037083.54166666
Debt to equity: 2.485329297131069
Current ratio: 1.9782080973241443
Quick ratio: 0.21281715020379602
Buyback yield (%): 0
Retained earnings: 12862500
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for ATEB.BR — quarterly report dated 2025-06-30
Capital expenditures: 0
Net tangible assets: 373772941.1764706
Buffett classification: The Gruesome
Stock price: 3.2
Shares outstanding: 60716353
Book value: 378200000.0000001
P/B ratio: 0.5137290576414595
Market cap (USD): 194292329.60000002
Debt to equity: 2.0577347808504673
Current ratio: 3.336619653321439
Quick ratio: 0.40659750526785315
Buyback yield (%): 0
Retained earnings: -11902352.94117647
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for ATEME.PA — annual report dated 2021-12-31
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 15.272727272727272
Shares outstanding: 11579407
Market cap (USD): 176849125.09090906
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for ATEME.PA — annual report dated 2022-12-31
Total revenue: 96332978.72340426
Gross profit: 57906382.97872341
Operating income: -167021.27659574468
Net income: -48936.17021276596
Capital expenditures: 2372340.425531915
Operating cash flow: -5776595.744680852
Depreciation & amortization: 4190425.531914894
Net tangible assets: 20926595.74468085
Owner earnings: 1769148.936170213
Buffett classification: The Gruesome
Stock price: 11.085106382978724
Shares outstanding: 11579407
Book value: 43553191.489361696
P/B ratio: 2.9471768671226193
Market cap (USD): 128358958.44680852
Debt to equity: 0.6423058133854422
Current ratio: 1.8575251889168767
Quick ratio: 1.5950094458438289
Interest coverage ratio: -0.3801452784503632
COGS to revenue (%): 39.889346570516715
R&D to revenue (%): 23.025189667929276
SG&A to revenue (%): 8.53975020153943
Free cash flow (dilution-adjusted): -10336170.212765958
Buyback yield (%): 0
Retained earnings: -48936.17021276596
Inventory turnover: 3.6102948525737126
Receivables turnover: 2.4089010667446993
Capitalized R&D asset: 22180851.063829787
ROCI (R&D-adjusted, %): 16.307907727359026
FCF margin (%): -10.72962795269069
Rule of 40 score: -10.72962795269069
Financial ratios for ATEME.PA — annual report dated 2023-12-31
Total revenue: 111146666.66666666
Gross profit: 66510000
Operating income: -2672222.222222222
Net income: -4438888.888888889
Capital expenditures: 2297777.7777777775
Operating cash flow: 696666.6666666666
Depreciation & amortization: 4575555.555555555
Net tangible assets: 18846666.666666668
Owner earnings: -2161111.1111111115
Return on net tangible assets (%): -11.466808159415166
Buffett classification: The Gruesome
Stock price: 7.822222222222222
Shares outstanding: 11579407
Book value: 42267777.777777776
P/B ratio: 2.1429254036434373
Market cap (USD): 90576694.75555556
Debt to equity: 0.8769748429326253
Current ratio: 1.8477417771232203
Quick ratio: 1.6489199803632792
Interest coverage ratio: -2.5369198312236287
COGS to revenue (%): 40.16014875239923
R&D to revenue (%): 24.389195457453617
SG&A to revenue (%): 9.583933141394754
Free cash flow (dilution-adjusted): -3770000
Buyback yield (%): 0
Retained earnings: -4438888.888888889
Inventory turnover: 4.959629629629629
Receivables turnover: 2.7514578061392894
Capitalized R&D asset: 41968947.99054374
ROCI (R&D-adjusted, %): 6.85726438710343
Rosenberg metric: 0.3878848920863308
FCF margin (%): -3.391914587332054
Revenue growth (%): 15.377587342955676
Rule of 40 score: 11.985672755623622
Financial ratios for ATEME.PA — annual report dated 2024-12-31
Total revenue: 97393750
Gross profit: 56463541.66666667
Operating income: -4093750
Net income: -5600000
Capital expenditures: 1818750
Operating cash flow: 4075000
Depreciation & amortization: 4372916.666666667
Net tangible assets: 13105208.333333334
Owner earnings: -3045833.333333333
Return on net tangible assets (%): -23.24139575550433
Buffett classification: The Gruesome
Stock price: 5.666666666666667
Shares outstanding: 11579407
Book value: 35000000
P/B ratio: 1.8747611333333334
Market cap (USD): 65616639.66666667
Debt to equity: 0.9663095238095238
Current ratio: 1.492272516288745
Quick ratio: 1.3739105021575067
Interest coverage ratio: -2.924107142857143
COGS to revenue (%): 42.02549787161223
R&D to revenue (%): 24.73956662174592
SG&A to revenue (%): 7.763802434276669
Free cash flow (dilution-adjusted): 410416.66666666674
Buyback yield (%): 0
Retained earnings: -5600000
Inventory turnover: 5.707044299201162
Receivables turnover: 2.1374391331184417
Capitalized R&D asset: 49576683.62884161
ROCI (R&D-adjusted, %): -3.9688824752018084
Rosenberg metric: -0.37061165307209887
FCF margin (%): 0.421399388222208
Revenue growth (%): -12.373665427063333
Rule of 40 score: -11.952266038841126
Financial ratios for ATEME.PA — quarterly report dated 2025-03-31
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 4.369565217391304
Shares outstanding: 11579407
Market cap (USD): 50596974.06521738
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for AZTA — annual report dated 2021-09-30
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 102.26
Shares outstanding: 46092804
Market cap (USD): 4713450137.04
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for AZTA — annual report dated 2022-09-30
Total revenue: 555498000
Gross profit: 255584000
Operating income: -23423000
Net income: 2132859000
Capital expenditures: 73435000
Operating cash flow: -466046000
Depreciation & amortization: 53702000
Net tangible assets: 2671362000
Owner earnings: 2113126000
Return on net tangible assets (%): 79.10294449048837
Buffett classification: The Gruesome
Stock price: 42.86
P/E ratio: 0.9262391838560354
Shares outstanding: 46092804
Book value: 3363386000
P/B ratio: 0.5873657021346941
Market cap (USD): 1975537579.44
Debt to equity: 0.014636143457813049
Current ratio: 10.667485013836718
Quick ratio: 10.296435418528189
Interest coverage ratio: -5.104162126825016
COGS to revenue (%): 53.99011337574573
R&D to revenue (%): 4.958073656430805
SG&A to revenue (%): 45.268389805183816
Free cash flow (dilution-adjusted): -554147000
Buyback yield (%): 0
Retained earnings: 1655356000
Inventory turnover: 3.5059618441971385
Receivables turnover: 3.3921884732348953
Capitalized R&D asset: 27542000
ROCI (R&D-adjusted, %): -0.1440790393794534
FCF margin (%): -99.75679480394169
Rule of 40 score: -99.75679480394169
Financial ratios for AZTA — annual report dated 2023-09-30
Total revenue: 551486000
Gross profit: 239210000
Operating income: -56669000
Net income: -14636000
Capital expenditures: 39436000
Operating cash flow: 5834000
Depreciation & amortization: 85584000
Net tangible assets: 1455860000
Owner earnings: 31512000
Buffett classification: The Gruesome
Stock price: 50.19
Shares outstanding: 46092804
Book value: 2534500000
P/B ratio: 0.9127630036535805
Market cap (USD): 2313397832.7599998
Debt to equity: 0.023845334385480373
Current ratio: 6.727205491921414
Quick ratio: 6.119424637791095
COGS to revenue (%): 56.62446553493652
R&D to revenue (%): 5.828071791487001
SG&A to revenue (%): 47.82315416891816
Free cash flow (dilution-adjusted): -42978000
Buyback yield (%): 36.24599228571122
Retained earnings: 1641009000
Inventory turnover: 2.4358882353858875
Receivables turnover: 3.523084294247293
Capitalized R&D asset: 50594140
ROCI (R&D-adjusted, %): -1.6299464021393066
Rosenberg metric: -0.5945102025996659
FCF margin (%): -7.793126208099571
Revenue growth (%): -0.7222348235277174
Rule of 40 score: -8.51536103162729
Financial ratios for AZTA — annual report dated 2024-09-30
Total revenue: 573448000
Gross profit: 254622000
Operating income: -39860000
Net income: -164897000
Capital expenditures: 37392000
Operating cash flow: 49743000
Depreciation & amortization: 90744000
Net tangible assets: 951396000
Owner earnings: -111545000
Return on net tangible assets (%): -11.724350323104154
Buffett classification: The Gruesome
Stock price: 48.44
Shares outstanding: 46092804
Book value: 1767847000
P/B ratio: 1.2629686990785967
Market cap (USD): 2232735425.7599998
Debt to equity: 0.03205990111135183
Current ratio: 4.042093464474086
Quick ratio: 3.6960293853626345
COGS to revenue (%): 55.59806643322498
R&D to revenue (%): 5.497272638495557
SG&A to revenue (%): 45.85559632259595
Free cash flow (dilution-adjusted): -2116000
Buyback yield (%): 29.63642679583333
Retained earnings: 1475719000
Inventory turnover: 4.470358945597308
Receivables turnover: 3.220930363180894
Capitalized R&D asset: 62147330
ROCI (R&D-adjusted, %): -1.9801600655313623
Rosenberg metric: 0.47951214959086524
FCF margin (%): -0.3689959682482108
Revenue growth (%): 3.982331373779208
Rule of 40 score: 3.613335405530997
Financial ratios for AZTA — quarterly report dated 2024-09-30
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 48.44
Shares outstanding: 46092804
Market cap (USD): 2232735425.7599998
Buyback yield (%): 11.149910425023185
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for AZTA — quarterly report dated 2024-12-31
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 50
Shares outstanding: 46092804
Market cap (USD): 2304640200
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for AZTA — quarterly report dated 2025-03-31
Total revenue: 143338000
Gross profit: 62783000
Operating income: -14614000
Net income: -47661000
Capital expenditures: 7408000
Operating cash flow: 14403000
Depreciation & amortization: 13953000
Net tangible assets: 907335000
Owner earnings: -41116000
Return on net tangible assets (%): -4.531512616619
Buffett classification: The Gruesome
Stock price: 34.64
Shares outstanding: 46092804
Book value: 1701492000
P/B ratio: 0.9383850941173982
Market cap (USD): 1596654730.56
Debt to equity: 0.03155818540433925
Current ratio: 3.219547557234961
Quick ratio: 2.8420392092898923
COGS to revenue (%): 56.199333044970636
R&D to revenue (%): 5.303548256568391
SG&A to revenue (%): 48.692600706023526
Free cash flow (dilution-adjusted): -1346000
Buyback yield (%): 0
Retained earnings: 1423043000
Inventory turnover: 0.9668030868568548
Receivables turnover: 0.9588467456017125
Capitalized R&D asset: 7602000
ROCI (R&D-adjusted, %): -0.5219776314048339
FCF margin (%): -0.9390391940727512
Rule of 40 score: -0.9390391940727512
Financial ratios for AZTA — quarterly report dated 2025-06-30
Total revenue: 143942000
Gross profit: 67760000
Operating income: 40000
Net income: -52806000
Capital expenditures: 10839000
Operating cash flow: 25810000
Depreciation & amortization: 14722000
Net tangible assets: 861884000
Owner earnings: -48923000
Return on net tangible assets (%): -5.676285903903541
Capex to operating income (%): 27097.500000000004
Buffett classification: The Gruesome
Stock price: 30.78
Shares outstanding: 46092804
Book value: 1673634000
P/B ratio: 0.8476981867720184
Market cap (USD): 1418736507.1200001
Debt to equity: 0.031445345876099554
Current ratio: 2.7643897569621285
Quick ratio: 2.4363762299590523
Effective tax rate (%): 80.22105875509017
COGS to revenue (%): 52.92548387544983
R&D to revenue (%): 4.64423170443651
SG&A to revenue (%): 42.40249544955607
Free cash flow (dilution-adjusted): 12537000
Buyback yield (%): 0
Retained earnings: 1370237000
Inventory turnover: 0.9462897175365811
Receivables turnover: 1.1558357088368731
Capitalized R&D asset: 11778340
ROCI (R&D-adjusted, %): 0.10992385752865907
Rosenberg metric: 0.6546961325966851
FCF margin (%): 8.709758097011296
Revenue growth (%): 0.4213816294353207
Rule of 40 score: 9.131139726446616
Financial ratios for AZTA — annual report dated 2025-09-30
Total revenue: 593821000
Gross profit: 270280000
Operating income: -21673000
Net income: -55763000
Capital expenditures: 33857000
Operating cash flow: 72181000
Depreciation & amortization: 61209000
Net tangible assets: 922777000
Owner earnings: -28411000
Return on net tangible assets (%): -3.078858705841173
Buffett classification: The Gruesome
Stock price: 28.72
Shares outstanding: 46092804
Book value: 1726986000
P/B ratio: 0.7665292775274379
Market cap (USD): 1323785330.8799999
Debt to equity: 0.02967250458312922
Current ratio: 2.9802965406396997
Quick ratio: 2.6649233824482272
COGS to revenue (%): 54.48460057828874
R&D to revenue (%): 5.117703819837964
SG&A to revenue (%): 44.04744864193082
Free cash flow (dilution-adjusted): 17443000
Buyback yield (%): 0
Retained earnings: 1419956000
Inventory turnover: 4.316412295213191
Receivables turnover: 3.9090573962043065
Capitalized R&D asset: 62117610
ROCI (R&D-adjusted, %): -1.2013990970465984
Rosenberg metric: 0.4967009262783911
FCF margin (%): 2.9374171677997243
Revenue growth (%): 3.5527196886204155
Rule of 40 score: 6.49013685642014
Financial ratios for AZTA — quarterly report dated 2025-09-30
Total revenue: 158951000
Gross profit: 67963000
Operating income: 1780000
Net income: 50839000
Capital expenditures: 7860000
Operating cash flow: 2170000
Depreciation & amortization: 14434000
Net tangible assets: 922777000
Owner earnings: 57413000
Return on net tangible assets (%): 6.221763221233299
Capex to operating income (%): 441.5730337078652
Buffett classification: The Gruesome
Stock price: 28.72
P/E ratio: 6.509693989260213
Shares outstanding: 46092804
Book value: 1726986000
P/B ratio: 0.7665292775274379
Market cap (USD): 1323785330.8799999
Debt to equity: 0.02967250458312922
Current ratio: 2.9802965406396997
Quick ratio: 2.6649233824482272
Effective tax rate (%): -789.6121883656509
COGS to revenue (%): 57.242798095010414
R&D to revenue (%): 6.578127850721291
SG&A to revenue (%): 35.05923209039264
Free cash flow (dilution-adjusted): -10684000
Buyback yield (%): 0
Retained earnings: 1419956000
Inventory turnover: 1.2138854794812957
Receivables turnover: 1.0463567003929983
Capitalized R&D asset: 17443610
ROCI (R&D-adjusted, %): 0.2168336554930535
Rosenberg metric: 0.030366492146596858
FCF margin (%): -6.721568282049185
Revenue growth (%): 10.427116477470094
Rule of 40 score: 3.705548195420908
Financial ratios for AZTA — quarterly report dated 2025-12-31
Total revenue: 148642000
Gross profit: 63706000
Operating income: -6094000
Net income: -15432000
Capital expenditures: 6192000
Operating cash flow: 20847000
Depreciation & amortization: 13648000
Net tangible assets: 915669000
Owner earnings: -7976000
Return on net tangible assets (%): -0.8710571178013016
Buffett classification: The Gruesome
Stock price: 33.26
Shares outstanding: 46092804
Book value: 1714832000
P/B ratio: 0.8939923333830953
Market cap (USD): 1533046661.04
Debt to equity: 0.031759379344448904
Current ratio: 2.918652909850943
Quick ratio: 2.6100676239554215
COGS to revenue (%): 57.141319411740966
R&D to revenue (%): 6.1819674116333205
SG&A to revenue (%): 40.77649654875473
Free cash flow (dilution-adjusted): 10597000
Buyback yield (%): 0
Retained earnings: 1404524000
Inventory turnover: 1.0300516626646292
Receivables turnover: 0.98991056028024
Capitalized R&D asset: 18400570
ROCI (R&D-adjusted, %): -0.3112180337837665
Rosenberg metric: -0.4071346595256312
FCF margin (%): 7.129209779201033
Revenue growth (%): -6.485646519996728
Rule of 40 score: 0.6435632592043046
Financial ratios for BTAI — annual report dated 2021-12-31
Capital expenditures: 445000
Buffett classification: The Gruesome
Stock price: 325.28
Shares outstanding: 30877605
Market cap (USD): 10043867354.4
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for BTAI — annual report dated 2022-12-31
Total revenue: 375000
Gross profit: 355000
Operating income: -159645000
Net income: -165757000
Capital expenditures: 139000
Operating cash flow: -135341000
Depreciation & amortization: 327000
Net tangible assets: 76775000
Owner earnings: -165569000
Return on net tangible assets (%): -215.65483555845
Buffett classification: The Gruesome
Stock price: 343.68
Shares outstanding: 30877605
Book value: 76775000
P/B ratio: 138.2222766056659
Market cap (USD): 10612015286.4
Debt to equity: 1.2222338000651254
Current ratio: 6.1665754757128095
Quick ratio: 6.106237461243845
Interest coverage ratio: -19.438085961280898
COGS to revenue (%): 5.333333333333334
R&D to revenue (%): 24330.4
SG&A to revenue (%): 18336.266666666666
Free cash flow (dilution-adjusted): -152817000
Buyback yield (%): 0
Retained earnings: -411545000
Inventory turnover: 0.010075566750629723
Receivables turnover: 1.5120967741935485
Capitalized R&D asset: 91239000
ROCI (R&D-adjusted, %): -37.403953155635634
FCF margin (%): -40751.2
Rule of 40 score: -40751.2
Financial ratios for BTAI — annual report dated 2023-12-31
Total revenue: 1380000
Gross profit: 120000
Operating income: -167619000
Net income: -179053000
Capital expenditures: 20000
Operating cash flow: -155006000
Depreciation & amortization: 318000
Net tangible assets: -56508000
Owner earnings: -178755000
Buffett classification: The Gruesome
Stock price: 47.2
Shares outstanding: 30877605
Book value: -56508000
Market cap (USD): 1457422956
Debt to equity: -1.7880300134494231
Current ratio: 2.645798951113067
Quick ratio: 2.5727802838596103
Interest coverage ratio: -12.589680036052275
COGS to revenue (%): 91.30434782608695
R&D to revenue (%): 6110.579710144928
SG&A to revenue (%): 6044.420289855073
Free cash flow (dilution-adjusted): -173640000
Buyback yield (%): 0
Retained earnings: -590598000
Inventory turnover: 0.6328478151682572
Receivables turnover: 19.43661971830986
Capitalized R&D asset: 145456130
ROCI (R&D-adjusted, %): -73.90371126933624
Rosenberg metric: -0.0025756529554247635
FCF margin (%): -12582.608695652174
Revenue growth (%): 268
Rule of 40 score: -12314.608695652174
Financial ratios for BTAI — quarterly report dated 2024-09-30
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 9.76
Shares outstanding: 30877605
Market cap (USD): 301365424.8
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for BTAI — quarterly report dated 2024-12-31
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 5.98
Shares outstanding: 30877605
Market cap (USD): 184648077.9
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for BTAI — annual report dated 2024-12-31
Total revenue: 2266000
Gross profit: 123000
Operating income: -64804000
Net income: -59599000
Capital expenditures: 0
Operating cash flow: -72027000
Depreciation & amortization: 309000
Net tangible assets: -93101000
Owner earnings: -59290000
Buffett classification: The Gruesome
Stock price: 5.98
Shares outstanding: 30877605
Book value: -93101000
Market cap (USD): 184648077.9
Debt to equity: -1.10173897165444
Current ratio: 1.6819142715782844
Quick ratio: 1.6513740835694688
Interest coverage ratio: -4.283429175755172
COGS to revenue (%): 94.57193292144748
R&D to revenue (%): 1343.1156222418358
SG&A to revenue (%): 1522.1535745807591
Free cash flow (dilution-adjusted): -78183000
Buyback yield (%): 0
Retained earnings: -650197000
Inventory turnover: 3.1561119293078055
Receivables turnover: 17.297709923664122
Capitalized R&D asset: 117042290
ROCI (R&D-adjusted, %): -77.38472684398359
Rosenberg metric: 3.557621611365415e-05
FCF margin (%): -3450.2647837599293
Revenue growth (%): 64.20289855072464
Rule of 40 score: -3386.061885209205
Financial ratios for BTAI — quarterly report dated 2025-03-31
Total revenue: 168000
Gross profit: 154000
Operating income: -10099000
Net income: -7254000
Capital expenditures: 0
Operating cash flow: -12043000
Depreciation & amortization: 76000
Net tangible assets: -90172000
Owner earnings: -7178000
Buffett classification: The Gruesome
Stock price: 2.03
Shares outstanding: 30877605
Book value: -90172000
Market cap (USD): 62681538.14999999
Debt to equity: -1.1741560573126912
Current ratio: 1.4787833711735692
Quick ratio: 1.4536522351835903
Interest coverage ratio: -2.529176058101678
COGS to revenue (%): 8.333333333333332
R&D to revenue (%): 2710.714285714286
SG&A to revenue (%): 3392.261904761905
Free cash flow (dilution-adjusted): -12223000
Buyback yield (%): 0
Retained earnings: -657451000
Inventory turnover: 0.021806853582554516
Capitalized R&D asset: 4554000
ROCI (R&D-adjusted, %): -40.19005348810743
FCF margin (%): -7275.595238095238
Rule of 40 score: -7275.595238095238
Financial ratios for BTAI — quarterly report dated 2025-06-30
Total revenue: 120000
Gross profit: 13000
Operating income: -15852000
Net income: -19187000
Capital expenditures: 0
Operating cash flow: -12575000
Depreciation & amortization: 75000
Net tangible assets: -107667000
Owner earnings: -19112000
Buffett classification: The Gruesome
Stock price: 1.81
Shares outstanding: 30877605
Book value: -107667000
Market cap (USD): 55888465.050000004
Debt to equity: -1.0118327807034653
Current ratio: 0.756321907957814
Quick ratio: 0.7411613135186961
Interest coverage ratio: -3.7546186641402177
COGS to revenue (%): 89.16666666666667
R&D to revenue (%): 8546.666666666666
SG&A to revenue (%): 4674.166666666667
Free cash flow (dilution-adjusted): -14131000
Buyback yield (%): 0
Retained earnings: -676638000
Inventory turnover: 0.21146245059288538
Receivables turnover: 7.0588235294117645
Capitalized R&D asset: 13307180
ROCI (R&D-adjusted, %): -184.13173478223882
Rosenberg metric: -0.030961791831357048
FCF margin (%): -11775.833333333334
Revenue growth (%): -28.57142857142857
Rule of 40 score: -11804.404761904763
Financial ratios for BTAI — quarterly report dated 2025-09-30
Total revenue: 98000
Gross profit: 87000
Operating income: -14034000
Net income: -30911000
Capital expenditures: 0
Operating cash flow: -18787000
Depreciation & amortization: 75000
Net tangible assets: -88919000
Owner earnings: -30836000
Buffett classification: The Gruesome
Stock price: 2.56
Shares outstanding: 30877605
Book value: -88919000
Market cap (USD): 79046668.8
Debt to equity: -1.2290511589199158
Current ratio: 1.1745582478044652
Quick ratio: 1.1624166754840757
Interest coverage ratio: -3.2092385090327005
COGS to revenue (%): 11.224489795918368
R&D to revenue (%): 8918.367346938776
SG&A to revenue (%): 5490.816326530612
Free cash flow (dilution-adjusted): -19368000
Buyback yield (%): 0
Retained earnings: -707549000
Inventory turnover: 0.023965141612200435
Capitalized R&D asset: 17114340
ROCI (R&D-adjusted, %): -54.53412407260042
Rosenberg metric: 0.007215288611544462
FCF margin (%): -19763.26530612245
Revenue growth (%): -18.333333333333332
Rule of 40 score: -19781.59863945578
Financial ratios for BTAI — quarterly report dated 2025-12-31
Total revenue: 256000
Gross profit: 224000
Operating income: -10282000
Net income: -12545000
Capital expenditures: 0
Operating cash flow: -14210000
Depreciation & amortization: 74000
Net tangible assets: -95463000
Owner earnings: -12471000
Buffett classification: The Gruesome
Stock price: 1.6
Shares outstanding: 30877605
Book value: -95463000
Market cap (USD): 49404168
Debt to equity: -1.1487068288237328
Current ratio: 0.8286355375885472
Quick ratio: 0.815246819715907
Interest coverage ratio: -2.3389444949954505
COGS to revenue (%): 12.5
R&D to revenue (%): 2617.578125
SG&A to revenue (%): 1486.328125
Free cash flow (dilution-adjusted): -14660000
Buyback yield (%): 0
Retained earnings: -720094000
Inventory turnover: 0.0443213296398892
Receivables turnover: 1.0987124463519313
Capitalized R&D asset: 15941280
ROCI (R&D-adjusted, %): -175.2442069382086
Rosenberg metric: 0.015675057208237985
FCF margin (%): -5726.5625
Revenue growth (%): 161.22448979591837
Rule of 40 score: -5565.338010204082
Financial ratios for BTAI — annual report dated 2025-12-31
Total revenue: 642000
Gross profit: 478000
Operating income: -50267000
Net income: -69897000
Capital expenditures: 0
Operating cash flow: -57615000
Depreciation & amortization: 300000
Net tangible assets: -95463000
Owner earnings: -69597000
Buffett classification: The Gruesome
Stock price: 1.6
Shares outstanding: 30877605
Book value: -95463000
Market cap (USD): 49404168
Debt to equity: -1.1487068288237328
Current ratio: 0.8286355375885472
Quick ratio: 0.815246819715907
Interest coverage ratio: -2.9596679227508242
COGS to revenue (%): 25.54517133956386
R&D to revenue (%): 4711.993769470405
SG&A to revenue (%): 3192.2118380062307
Free cash flow (dilution-adjusted): -60382000
Buyback yield (%): 0
Retained earnings: -720094000
Inventory turnover: 0.22714681440443213
Receivables turnover: 2.755364806866953
Capitalized R&D asset: 78470030
ROCI (R&D-adjusted, %): -98.40671438427732
Rosenberg metric: 0.011664202398554296
FCF margin (%): -9405.295950155763
Revenue growth (%): -71.66813768755517
Rule of 40 score: -9476.964087843318
Financial ratios for CATY — annual report dated 2021-12-31
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 37.2
Shares outstanding: 66825367
Market cap (USD): 2485903652.4
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for CATY — annual report dated 2022-12-31
Total revenue: 790511000
Net income: 360642000
Capital expenditures: 3390000
Operating cash flow: 467357000
Depreciation & amortization: 19803000
Net tangible assets: 2092587000
Owner earnings: 377055000
Return on net tangible assets (%): 18.018605678043492
Buffett classification: The Gruesome
Stock price: 36.42
P/E ratio: 6.7484648658226165
Shares outstanding: 66825367
Book value: 2474040000
P/B ratio: 0.98372696728428
Market cap (USD): 2433779866.1400003
Debt to equity: 0.2664686100467252
Effective tax rate (%): 23.67946569150287
COGS to revenue (%): 0
SG&A to revenue (%): 19.91699040241059
Free cash flow (dilution-adjusted): 456135000
Buyback yield (%): 5.80644132881782
Retained earnings: 2244855000
Receivables turnover: 9.59032125006066
Capitalized R&D asset: 0
FCF margin (%): 57.701284359104434
Rule of 40 score: 57.701284359104434
Financial ratios for CATY — annual report dated 2023-12-31
Total revenue: 810038000
Net income: 354124000
Capital expenditures: 3401000
Operating cash flow: 384742000
Depreciation & amortization: 18104000
Net tangible assets: 2356418000
Owner earnings: 368827000
Return on net tangible assets (%): 15.652019293690678
Buffett classification: The Gruesome
Stock price: 41.33
P/E ratio: 7.799224051772825
Shares outstanding: 66825367
Book value: 2736575000
P/B ratio: 1.0092514979892748
Market cap (USD): 2761892418.1099997
Debt to equity: 0.25934608041073237
Effective tax rate (%): 12.254758636410939
COGS to revenue (%): 0
SG&A to revenue (%): 22.668566166031717
Free cash flow (dilution-adjusted): 373505000
Buyback yield (%): 0.6034630418879767
Retained earnings: 2500341000
Receivables turnover: 8.293366641753606
Capitalized R&D asset: 0
FCF margin (%): 46.10956523027315
Revenue growth (%): 2.470174355575065
Rule of 40 score: 48.579739585848216
Financial ratios for CATY — quarterly report dated 2024-09-30
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 40.88
Shares outstanding: 66825367
Market cap (USD): 2731821002.96
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for CATY — quarterly report dated 2024-12-31
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 45.61
Shares outstanding: 66825367
Market cap (USD): 3047904988.87
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for CATY — annual report dated 2024-12-31
Total revenue: 729719000
Net income: 285979000
Capital expenditures: 3636000
Operating cash flow: 329155000
Depreciation & amortization: 16829000
Net tangible assets: 2467062000
Owner earnings: 299172000
Return on net tangible assets (%): 12.126651052952866
Buffett classification: The Gruesome
Stock price: 45.61
P/E ratio: 10.657793015815846
Shares outstanding: 66825367
Book value: 2845704000
P/B ratio: 1.0710548211866027
Market cap (USD): 3047904988.87
Debt to equity: 0.08002483743917146
Effective tax rate (%): 9.939787492678134
COGS to revenue (%): 0
SG&A to revenue (%): 25.78732361361017
Free cash flow (dilution-adjusted): 318715000
Buyback yield (%): 2.779056443993792
Retained earnings: 2688353000
Receivables turnover: 7.462941940498471
Capitalized R&D asset: 0
FCF margin (%): 43.67640146412523
Revenue growth (%): -9.915460756162057
Rule of 40 score: 33.76094070796317
Financial ratios for CATY — quarterly report dated 2025-03-31
Total revenue: 187843000
Net income: 69506000
Capital expenditures: 2698000
Operating cash flow: 98959000
Depreciation & amortization: 4140000
Net tangible assets: 2486362000
Owner earnings: 70948000
Return on net tangible assets (%): 2.8534863386747387
Buffett classification: The Gruesome
Stock price: 41.52
P/E ratio: 9.979675272062845
Shares outstanding: 66825367
Book value: 2865159000
P/B ratio: 0.9683892718833407
Market cap (USD): 2774589237.84
Debt to equity: 0.09212473025057248
Effective tax rate (%): 19.819580790660652
COGS to revenue (%): 0
SG&A to revenue (%): 25.395676176381336
Free cash flow (dilution-adjusted): 94756000
Buyback yield (%): 1.4944554471162095
Retained earnings: 2734004000
Receivables turnover: 1.9617043496423163
Capitalized R&D asset: 0
FCF margin (%): 50.44425397805614
Rule of 40 score: 50.44425397805614
Financial ratios for CATY — quarterly report dated 2025-06-30
Total revenue: 196612000
Net income: 77450000
Capital expenditures: 1262000
Operating cash flow: 63952000
Depreciation & amortization: 4060000
Net tangible assets: 2507711000
Owner earnings: 80248000
Return on net tangible assets (%): 3.2000497665002072
Buffett classification: The Gruesome
Stock price: 44.29
P/E ratio: 20.14001132604317
Shares outstanding: 66825367
Book value: 2886295000
P/B ratio: 1.0254307007530414
Market cap (USD): 2959695504.43
Debt to equity: 0.20202092994652313
Effective tax rate (%): 19.555869461351502
COGS to revenue (%): 0
SG&A to revenue (%): 24.115008239578458
Free cash flow (dilution-adjusted): 60487000
Buyback yield (%): 1.2120503594476584
Retained earnings: 2787608000
Receivables turnover: 2.0343521718436355
Capitalized R&D asset: 0
FCF margin (%): 30.76465322564238
Revenue growth (%): 4.668260196014757
Rule of 40 score: 35.43291342165714
Financial ratios for CATY — quarterly report dated 2025-09-30
Total revenue: 210608000
Net income: 77651000
Capital expenditures: 495000
Operating cash flow: 150596000
Depreciation & amortization: 4029000
Net tangible assets: 2523913000
Owner earnings: 81185000
Return on net tangible assets (%): 3.216632269020366
Buffett classification: The Gruesome
Stock price: 47.02
P/E ratio: 13.98945160364548
Shares outstanding: 66825367
Book value: 2902276000
P/B ratio: 1.0826429865181673
Market cap (USD): 3142128756.34
Debt to equity: 0.1239864850896331
Effective tax rate (%): 17.181100682593854
COGS to revenue (%): 0
SG&A to revenue (%): 22.66723011471549
Free cash flow (dilution-adjusted): 148098000
Buyback yield (%): 1.6098958356793178
Retained earnings: 2842016000
Receivables turnover: 2.1925771693300713
Capitalized R&D asset: 0
FCF margin (%): 70.31926612474359
Revenue growth (%): 7.118588895896487
Rule of 40 score: 77.43785502064009
Financial ratios for CATY — annual report dated 2025-12-31
Total revenue: 817892000
Net income: 315124000
Capital expenditures: 4911000
Operating cash flow: 368569000
Depreciation & amortization: 16036000
Net tangible assets: 2547692000
Owner earnings: 326249000
Return on net tangible assets (%): 12.805668817109762
Buffett classification: The Gruesome
Stock price: 47.72
P/E ratio: 10.119529179751463
Shares outstanding: 66825367
Book value: 2925388000
P/B ratio: 1.090079850344638
Market cap (USD): 3188906513.24
Debt to equity: 0.05907592428765005
Effective tax rate (%): 19.2399756021302
COGS to revenue (%): 0
SG&A to revenue (%): 23.818792701236838
Free cash flow (dilution-adjusted): 356048000
Buyback yield (%): 5.653599415707656
Retained earnings: 2909677000
Receivables turnover: 8.432484818492057
Capitalized R&D asset: 0
FCF margin (%): 43.53239792050784
Revenue growth (%): 12.083144333640758
Rule of 40 score: 55.6155422541486
Financial ratios for CATY — quarterly report dated 2025-12-31
Total revenue: 222829000
Net income: 90517000
Capital expenditures: 456000
Operating cash flow: 55062000
Depreciation & amortization: 3807000
Net tangible assets: 2547692000
Owner earnings: 93868000
Return on net tangible assets (%): 3.6844328121295664
Buffett classification: The Gruesome
Stock price: 47.72
P/E ratio: 10.119529179751463
Shares outstanding: 66825367
Book value: 2925388000
P/B ratio: 1.090079850344638
Market cap (USD): 3188906513.24
Debt to equity: 0.05907592428765005
Effective tax rate (%): 20.230363170093327
COGS to revenue (%): 0
SG&A to revenue (%): 23.31653420335773
Free cash flow (dilution-adjusted): 52707000
Buyback yield (%): 1.6420989383848696
Retained earnings: 2909677000
Receivables turnover: 2.297371975297186
Capitalized R&D asset: 0
FCF margin (%): 23.65356394365186
Revenue growth (%): 5.802723543265214
Rule of 40 score: 29.456287486917073